95 Current news about the topic biomarker

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
A prognostic Alzheimer’s disease blood test in the symptom-free stage

Memory deficit is a normal side effect of aging. At what point does memory loss become pathological?

08-Jan-2021

Using a blood test, a German-Dutch research team has predicted the risk of Alzheimer’s disease in people who were clinically diagnosed as not having Alzheimer’s disease but who perceived themselves as cognitively impaired (Subjective Cognitive Declined, SCD). The researchers analyzed blood ...

more

image description
New tests identify very early changes in Alzheimer's disease before symptoms appear

07-Dec-2020

Researchers at the University of Gothenburg in Sweden, together with their colleagues at the Barcelona Beta Research Centre in Spain, the University Medical Centre in Ljubljana, Slovenia, and the University of Paris, have found new forms of tau protein that become abnormal in the very early ...

more

image description
COVID-19: Release of immature blood cells from bone marrow as a signature of severe disease

Research team has identified cell types in the blood that indicate severe disease progression in COVID-19

30-Nov-2020

In severe cases of COVID-19 disease, not only classic immune cells play a role. In particular, the release of immature precursor cells from the bone marrow into the blood indicates a particularly severe course of the disease and could contribute to complications. This has been shown by an ...

more

image description
Bruker Announces Acquisition of Canopy Biosciences, LLC

Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging

16-Sep-2020

Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s global ...

more

image description
Could the blood of COVID-19 patients be used to predict disease progression?

Study discovers differences in the blood samples of severe and mild cases

09-Jun-2020

Researchers from Charité – Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms. These biomarker profiles could be used to predict disease ...

more

image description
Amplification and imaging of microRNA as a biomarker to detect tumor development

Cancer Diagnostics

18-Mar-2020

A good indicator of dysregulation in live cells is a change in their RNA expression. MicroRNA (miRNA), a special type of RNA, is considered a biomarker for carcinogenic cells. A team of scientists from China has found a way to amplify miRNA in live tumor cells for bioimaging. As they report in ...

more

image description
Chip-based optical sensor detects cancer biomarker in urine

New technology lays groundwork for biosensors that improve disease diagnosis and monitoring

09-Dec-2019

For the first time, researchers have used a chip-based sensor with an integrated laser to detect very low levels of a cancer protein biomarker in a urine sample. The new technology is more sensitive than other designs and could lead to non-invasive and inexpensive ways to detect molecules that ...

more

image description
Blood samples from the zoo help predict diseases in humans

17-Jul-2019

Penguins, Asian elephants and many other animal species live in the zoos of Saarbrücken and Neunkirchen. As they come from different continents, blood is regularly taken from the animals to check their health. These blood samples have now been used by bioinformaticians and human geneticists at ...

more

image description
Protein content as a marker for response to therapy in brain cancer

Look into the future in fact seems possible

06-Mar-2019

Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-invasive ...

more

Antibodies to a retina protein to be used as a kidney cancer marker

Suggestion of new method for diagnosing kidney cancer

22-Jan-2019

Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer. This method is based on measuring of the immune response to arrestin-1, a retina protein that is synthesized in the cancerous cells of ...

more

Page 1 From 10
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE